FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1)

The summary for the FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1): The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others. The research proposed must be in an area described in the Trans NIH Plan for HIV-Related Research http://www.oar.nih.gov/strategicplan/.
Federal Grant Title: FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-12-011
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Mar 27, 2012
Original Application Deadline: Mar 27, 2012
Posted Date: Jul 29, 2011
Creation Date: Jul 29, 2011
Archive Date: Apr 27, 2012
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/rfa-da-12-011.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Epidemiology of Drug Abuse (R21)
Epidemiology of Drug Abuse (R03)
Epidemiology of Drug Abuse (R01)
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School...
Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Family and Interpersonal Relationships in an Aging Context (R01)
Administrative Supplements for Tobacco Regulatory Research on the Public Display of Harmfu...
Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33)
BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and C...
Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com